Clinical Trial Update: Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sublingual methadone for cancer-related procedure pain in inpatients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Methadone (sublingual) (methadone)

Snippet

Sponsor: Alberta Health services | Conditions: Cancer, Pain | Phase 2 | Status: TERMINATED